Media & News

Orchidia has achieved unprecedented growth rates in its total sales, with the company achieving a total growth of ( 174 %) in the first half.
Read More
The Board of Directors of Orchidia have agreed to increase the company's investments in eye medicines production for the years 2017-2018 to 200 million Egyptian pounds, as a result of the increasing demand for the company's products in both the local and export market.
Read More
Orchidia acquired a market share of 36.8% of the IMS dry eye market, according to the company's data to lead the market with sales of 50 million pounds in the first half of 2017
Read More
Orchidia is starting to install the new line of Single Dose Unit (SDU) eye drops which are single-use droplets that are free of preservatives as it will be shipped that produced by Rommelag - Switzerland to Egypt and will begin installation in September 2017.
Read More
Orchidia Pharmaceutical Industries obtained the approval of Sudan Ministry of Health to register five of the company's eye drops, as the company obtained the pricing certificates of the 5 products in accordance with the regulations adopted in Sudan.
Read More
May 15, 2017, Egypt Orchidia Pharmaceutical Industries has begun the introduction of Bromoflam in the Egyptian market through Hospitals and Pharmacies. Bromoflam is a product containing Bromfenac Sodium in a 5 ml eye drop; it is an anti-inflammatory, non-steroidal eye drop characterized by its efficacy in the treatment of pain associated with surgery and eye inflammation pain. Bromoflam is the first and only eye product in Egypt to contain the active ingredient Bromfenac Sodium. Orchidia plans to make the Bromoflam the market leader of the as anti-inflammatory non-steroidal eye drops market in Egypt during the coming two years. Bromoflam is priced at 25 Egyptian pounds for the public.
Read More
The Egyptian-American Enterprise Fund (“EAEF”) announced today that it has entered into binding agreements to acquire a significant minority stake in Orchidia Pharmaceutical Industries the leading Egyptian ophthalmic generic medicine manufacturer and one of the fastest growing pharmaceutical companies in Egypt.
Read More
Orchidia Pharmaceutical Company launched its two products in Sudan. Tears Guard and Poly-fresh eye drops are now available in the Sudanese market. It is expected to launch more products during the year 2018.
Read More
The remarkable team has successfully installed the Romelage machines (SDU) in the production area which initiated the first phase of the assembly process. This machine will contribute to the technological development of the eye drops filling for the local and international markets.
Read More
The press conference for one of our successful campaign “Enak Fe Enena “to combat blindness.
Read More
The optometry conference was held in Corinthia hotel in el Khartoum Sudan
Read More
The Egyptian Ophthalmological Soceity honored Dr. Ossama Abbasو the Chief Executive Officer of Orchidia Pharmaceutical company, for his efforts in the CME programs (continued medical education ) and for “Enek Fe Enena “
Read More
We are glad to announce the beginning of Orchidia Wet-lab at Orchidia Pharmaceutical premises. The wave one (from 1 / 4 till 15/5/2018) will cover the basic course in Phaco Emulsification (Cataract Surgery). For registration call the company medical representative in your Area.
Read More
Our team in Jordan participated in a patient screening campaign at Macca mall in Amman for detecting patients with Glaucoma,
Read More
Orchidia Pharmaceutical Industries factory has been registered in Bahrain, as a part of Orchidia’s regional expansion plan.
Read More
Travonorm Plus Eye drops is now available in the Egyptian market
Read More
On Thursday, 19/7/2018, the press conference of "Great Minds" second wave initiative has been held at one of the top ranked hotels in Cairo for signing the protocol of cooperation between Orchidia Pharmaceutical company and the Egyptian Association for Continuing Medical Education
Read More
The first wave of Great Minds 2018 was held on Friday 27/7/2018 at Conrad Cairo hotel with great success.
Read More
Orchidia Pharmaceutical Industries factory has been registered in The United Arab Emirates
Read More
Gatistar 0.3% eye drops is now available in a new package and it's new name is Gatyxel 0.3%
Read More
Orchidia Seminar in Al-Zarqa Eye Center in Khartoum - Sudan,with attendance of 15 ophthalmic consultants
Read More
Orchidia participation in the annual meeting of Iraqi ophthalmological society ( from 15/11 till 16/11/2018)
Read More
Orchidia Seminar in National Ribat University, Sudan.
Read More
Orchidia’s participation in SAFO conference ( from 3/12 : 6/12/2018 ), Togo, West Africa
Read More
Twinzol SDU is Now Available
Read More
Orchidia’s participation in Alex Ophthalmology Summit
Read More
Orchidia’s participation in the conference of Senegal ophthalmic society,from 12/4 to13/4/2019
Read More
Basic Phaco Emulsification wet lab ( Cataract Surgery ) is now available at Orchidia Pharmaceutical Company
Read More
Orchidia's participation in MEACO conference from 5/9 to 8/9/2019 in Dead Sea, Jordan.
Read More
SDU eye Drops for Glaucoma Treatment
Read More
Launch of Normoprost eye drops (Latanoprost ) in Jordan
Read More
Ocuguard launch in Burkina Faso (West Africa )
Read More
Doctors Visit from  Sohag Governorate to Orchidia Pharmaceutical factory
Read More
Doctors Visit of Sohag Governorate to Orchidia Pharmaceutical factory
Read More
Orchidia’s participation in SAFO conference which was held in Mali (West Africa) from 2 /12 till 5/12/2019
Read More
Orchidia’s Quality control labs have been awarded the ISO/IEC 17025:2017 accreditation by Egyptian Accreditation Council (EGAC).
Read More
We are pleased to announce that the packaging design for Gatistar 0.5 Eye drops has been changed to new design.
Read More
Orchidia’s participation in the 21st Sudanese Ophthalmology conference
Read More
For complaints and suggestions please contact Orchidia Pharmaceutical Industries
Read More
Orchidia’s participation in the 2nd international conference of the Gabonese Society of Ophthalmology. The conference was held in Libreville, the Gabonese capital, on 28 and 29 February 2020
Read More
The international live webinars "Glaucoma & Neuro-Ophthalmology ", organized by Orchidia Pharmaceutical Industries in cooperation with City Eye Center and the Jordan Ophthalmologists Association.
Read More
Dear Doctor; You are cordially invited to attend the international live webinar meeting "Fungal Keratitis" by Dr. El-Nazir Mohamed Adam, organized by Orchidia Pharmaceutical Industries.
Read More
Dear Doctor; You are invited to attend the international live webinars of "Diabetic Retinopathy and Oculoplasty", organized by Orchidia Pharmaceutical Industries in cooperation with City Eye center and the Jordan Ophthalmologists Association.
Read More
Twinzole eye drops (Dorzolamide hydrochloride 2% and Timolol 0.5% ) is registered now in the Kingdom of Saudi Arabia
Read More
Orchidia Pharmaceutical Company mourns Prof. Dr. Hassan Jamal Al-Din Farhat
Read More
The international live webinar meeting "Cataract in difficult situation. How to be ready?", organized by Orchidia Pharmaceutical Industries
Read More
The live webinar meeting "When Glaucoma Meets Cataract", sponsored by Orchidia Pharmaceutical company.
Read More
The first wave of Great Minds Webinar 2020 - A new Era of great Minds
Read More
Orchidia Pharmaceuticals Launches 3 Initiatives to Support Egypt’s Efforts against Coronavirus
Read More
There is no need now to store Ioprost eye drops in the fridge
Read More
The first live webinar of Glaucomatology 2020( Glaucoma CME) “ Tips to a comprehensive Glaucoma Examination, sponsored by Orchidia Pharmaceutical company .
Read More
The second session of Glaucomatology 2020( Glaucoma CME)“ The visual field: towards a better understanding of its clinical importance in the diagnosis and follow up of Glaucoma”, sponsored by Orchidia Pharmaceutical company .
Read More
The Third live session of Glaucomatology 2020( Glaucoma CME) “ The Optic Disc in Glaucoma, Clinical Evaluation and OCT Interpretation”, sponsored by Orchidia Pharmaceutical company .
Read More
As a part of Orchidia’s global expansion strategy and especially in African continent, we are glad to announce the registration of Orchidia Pharmaceutical Company in the Democratic Republic of Congo
Read More
A new wave of "Eineak Fi Einena" campaign will start by January 2021 “ Enek Fi Enena - عنيك فى عنينا" is one of our most successful CSR campaigns
Read More
Orchidia's participation in the 20th annual congress of the Egyptian Society for the Glaucomas, Friday 31/10/2020
Read More
We are pleased to announce the launch of Orchidia's wetlab project 2020 with new facilities and techniques to serve you better.
Read More
The 32nd Annual Meeting of ESOIRS2020 .
Read More
Avazir eye ointment (Tobramycin 0.3), the new advanced formula, is one of our new products which is available now in Egyptian market.
Read More
ِAscozinc ( vitamin C & zinc ), now available in Egyptian market
Read More
Honoring Dr. Osama Abbas - Chief Executive Officer of Orchidia Pharmaceutical Industries
Read More
Conjyclear Forte SDU, Anti-allergic eye drops, is available now in the Egyptian market
Read More
"Al Youm7" newspaper covered the new expansions of Orchidia company in the field of cosmeceutical products and food supplements.
Read More
Now Available in the Egyptian market! Pentolegic SDU, the first preservative free cyclopentolate eye drops.
Read More
Now available in the Egyptian market! Lenzy, the contact lens solution.
Read More
Orchidia vaccinated all employees against Covid over two days at the company’s headquarters in Al Obour city.
Read More
Orchidia vaccinated all employees against Covid over two days at the company’s headquarters in Al Obour city.
Read More
See The Impact”, the first project in Egypt concerned with ocular surface diseases and the new generation of preservative free eye drops.
Read More
Co-Avazir eye ointment, the new advanced formula, is available now in the Egyptian market.
Read More
Orchidia Magazine Volume 1 Issue 1 https://orchidiapharma.com/Orchidia_Magazine/1/
Read More
Orchidia's participation, as a main sponsor, in 5th Yemeni Ophthalmic Society conference
Read More
The first scientific meeting of “See The Impact” project, the first of its kind in the Middle East related to the effect of eye drops, containing preservatives, on the surface of the eye, sponsored by Orchidia.
Read More
The 10th Anniversary celebration of Polyfresh Brand in the Egyptian market and overseas. Advancing to a new level to reach patient satisfaction with the highest medical efficacy.
Read More
The Export Council of Medical Industries honored Orchidia Pharmaceutical Industries for its role in increasing Egyptian pharmaceutical exports and opening new international markets.
Read More
en_USEnglish
No products in the cart.